Texas cancer probe draws NCI scrutiny

December 14, 2012 by Paul J. Weber

(AP)—The federal National Cancer Institute says it's taking a fresh look at a troubled $3 billion cancer-fighting effort already being scrutinized by prosecutors and lawmakers in Texas.

The U.S. government's agency confirmed Friday that upheaval within the Cancer Prevention and Research Institute of Texas caught its attention. NCI spokeswoman Aleea Farrakh Khan told The Associated Press that officials are "evaluating recent events" at CPRIT.

CPRIT is on an exclusive list of NCI-approved funding entities, which includes the . The designation is a federal seal-of-approval that signals high peer review standards and conflict of interest policies.

Khan says NCI has made no decisions about CPRIT or contacted the agency directly.

Prosecutors are investigating CPRIT following an $11 million award to a private company that bypassed review.

Explore further: Researchers train promotoras to combine mobile technology, cancer prevention messages


Related Stories

Prevalence of screening for Lynch syndrome varies

February 24, 2012

(HealthDay) -- Screening for Lynch syndrome, the most common form of inherited colorectal cancer, after a colorectal cancer diagnosis is common at comprehensive cancer centers but not community hospitals, according to a study ...

Cancer agency OK'd faulty $11M grant

November 29, 2012

(AP)—Texas' embattled $3 billion cancer-fighting agency approved an $11 million grant to a biomedical company even though the proposal wasn't reviewed.

Recommended for you

Compound doubles up on cancer detection

October 8, 2015

Tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer, according to a study published last week in the Proceedings of the ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.